- Jul 4, 2002
So masks should not be mandated then. Agree that it's a good idea when one has a respiratory infection but then think that people with other conditions, like sinus infections and hayfever will be unfairly targetted by vigilante people if they sneeze etc.The problem is that the mask should be worn by the one who has the infection.Unfortunately I don't see western societies taking up this practice despite it's usefulness.
Results of Sinovac in Chile.Basically it's efficacy was 77% at 3 weeks following second dose and IgG antibody levels began to fall after 4 weeks.
Reasons for anti body testing..... instead of looking at vaccination records.Not surprising given the significant number of Doctors and Nurses fully vaxed with the Chinese vaccines in Indonesia who died, and why they are being given moderna and pfizer boosters. Important that we do not recogise people who have had this vaccine as fully vacinated, irrespectuve that WHO endorsed such an under performing vaccine.
Data collected from 18 states between March and August suggest the Pfizer-BioNTech vaccine reduces the risk of being hospitalized with COVID-19 by 91% in the first four months after receiving the second dose. Beyond 120 days, however, that vaccine efficacy drops to 77%.
Meanwhile, Moderna’s vaccine was 93% effective at reducing the short-term risk of COVID-19 hospitalization and remained 92% effective after 120 days.
Probably not a lot of relevance for Australia but at least it adds another effective option.
On 25 June 2021 the Therapeutic Goods Administration (TGA) granted provisional approval to Janssen-Cilag Pty Ltd (known as Johnson & Johnson overseas) for its COVID-19 vaccine Janssen
Read this article - it mentions a 'special ventilator' being trialled - is it all just talk or could it be some form of treatment to prevent potential long term effects?